Relais announced today that Christian Johansson Gebauer, former head of Ratos Construction & Service...
* Acquires NetApp partner Consular for DKK 65m, adds 3% to sales, 7% to EBITA * 4.
* Sales SEK 14m vs. ABGSCe 10m, EBIT in line at SEK -12m * No machine deliveries in the quarter (in ...
Redeye sees a Q3 report from Physitrack largely in line with our expectations.
Redeye provides its initial take on Indutrade’s Q3 2025 report, which beat our profit estimates desp...
Redeye provides an update following Q-linea’s Q3 2025 report.
Redeye is positive about the updated data from Paxman’s CIPN clinical trial in Singapore.
Ahead of CapMan's Q3 2025 results on 6 November, we only make minor revisions to our adjusted EBIT e...
Insplorion has signed an LoI with Mann Tek, a major manufacturer of couplings for fluids and gases.
* Seasonally weaker volumes to weigh on earnings * 10-12% '26e-'27e sales growth, 21-22% EBIT margin...
Redeye comments on Active Biotech’s proposed fully guaranteed rights issue of SEK70m, which is large...
* Q3 softer due to sizeable customer trimming '25 volumes * '25e-'27e sales cut by 11-6% and '26e-'2...
We maintain our estimates intact ahead of Relais Q3 report.
Redeye provides an initial take following Q-linea’s Q3 2025 report.
* Q3 sales lower than expected (-5% vs. ABGSCe) * Major untapped potential in Recycling * Long-term ...
Redeye updates its estimates and fair value range following Waystream’s Q3 report.
Following the positive profit warning on 13 October, we nudge up our 2025-27 estimates by 3-5%.
* Q3 report due on 23 October * We cut 2025e EBITA by 3% but raise 2026e-2027e by 3-2% * Share is tr...
* Q3 report due 23 October; we cut '25e-'27e EPS by ~2% * We expect further margin and cash flow rec...
Redeye provides a short comment on GB-A negative decision relating to reimbursement on the German ma...
